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Subcortical band heterotopia (SBH), also known as ‘double
cortex’ syndrome, is characterized by a band of heterotopic
neurons interspersed in the white matter between the cortex and
the lateral ventricles and is usually a severe disease with patients
showing variable degrees of developmental delay, intellectual
disability, motor impairment and epilepsy [1].
This is a true neuronal migration disorder that in the majority of
the cases is due to defects in the doublecortin gene (DCX) [1]. As
DCX is located on the X-chromosome, patients usually show a de
novo mutation or inherit the mutated allele from the mother. Here
we describe a woman with epilepsy due to SBH that inherited a
DCX mutation from her father.
2. Clinical case
We present a 24 years old woman with severe intellectual
disability having completed only two years of basic education.
At the age of 13, she developed focal epilepsy with motor
seizures with secondary generalization that were refractory to
antiepileptic drugs. During the seizures she ﬁrst turns her head to
the side, then stretches the four limbs and her breath becomes
noisy. She bits her tongue, but had no sphincter incontinence. If
standing, she falls and can injure herself. In the post-ictal period
she becomes very tired and usually falls asleep. Electroencephalo-
gram showed focal paroxysmal left fronto-temporal activity with
bilateralization. Brain magnetic resonance (MRI) showed a very
thin and relatively symmetric frontal bilateral subcortical band* Corresponding author.
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subcortical differentiation in some areas (Fig. 1).
The patient is currently treated with daily carbamazepine
1000 mg and topiramate 200 mg, having, on average, one seizure
per month.
Her father, now 50 years old, had seizures from 16 years of age.
He was treated with carbamazepine and the seizures remitted
around the age of 25–30 years. At that time he stopped treatment
without recurrence. He never had cognitive or learning problems.
His neurological exam is normal. His brain MRI showed subcortical
band heterotopia with frontal bilateral subcortical thin streaks
with a signal identical to the cortex (Fig. 1).
Mutation screening of DCX was performed by PCR ampliﬁcation
followed by direct bidirectional sequencing of the entire coding
regions and intronic ﬂanking sequences. The study revealed, in the
affected patient, the presence of a heterozygous c.577A>G
substitution in DCX that replaces a highly conserved tyrosine by
a cysteine (p.Tyr186Cys) predicted to be probably damaging by
different bioinformatic analysis software’s (PolyPhen-2, SIFT and
MutationTaster). Additionally, this mutation was not present in
dbSNP131 or in the 1000 genomes database. The same mutation
was identiﬁed in the father in mosaic (Fig. 2). Mutation load was
accessed by next-generation sequencing using an Ion Torrent
PGMTM platform after ION XpressTM Plus Fragment Library Kit
workﬂow. Data analysis was performed using SeqNext (JSITM) and
allowed the detection, in the father, of a mutation burden of 54% in
peripheral blood lymphocytes.
3. Discussion
The DCX gene is located on chromosome Xq22.3-q23 and is
composed of nine exons (six coding exons) that encode a 360served.
Fig. 1. Patient (left panel) and father’s (right panel) brain magnetic resonance with subcortical band heterotopia.
Fig. 2. Electropherogram of DCX exon 2 from a healthy individual (left panel), from this family patient (middle panel) and her mosaic father (right panel), both showing the A-
to-G substitution at position 557 (arrows), resulting in the replacement of a highly conserved tyrosine by cysteine at position 186.
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family of neuronal microtubule-associated proteins essential for
neuronal migration. It is expressed in the migrating and
differentiating neurons and is fundamental to the organization
of the microtubule cytoskeleton [3].
Neurons that originate in the periventricular areas and migrate
radially, in the absence of adequate amounts of this protein, will
eventually migrate very slowly. Many will end their migration
prematurely and instead of reaching the cerebral cortex, will settle
in a deeper heterotopic position creating the double cortex [1].
The brain malformation is often revealed by the appearance of
seizures within the ﬁrst decade of life and usually evolves to
refractory and multifocal epilepsy. Neurological examination is
usually normal, but hypotonia, poor ﬁne motor control and
behavioural disturbances may be present [3].
As DCX is a X chromosome gene, males are hemizygous having
only the mutated allele and tend to express a more severe
phenotype, while females are heterozygous showing usually a
milder phenotype [1]. Thus, in the case of a female patient with SBH
this usually means two possibilities: a de novo mutation or an
inherited mutation from a heterozygous asymptomatic mother. In
the family presented here a female patient showed typical clinical
and imagiological phenotype of SBH. The father is a somatic mosaic
for the p.Tyr186Cys mutation and, despite the clearly identiﬁable
subcortical band in the brain MRI, he had a very mild clinicalphenotype with no developmental delay or cognitive impairment
and only transient epilepsy, being asymptomatic for more than 20
years without treatment.
The father, being a mosaic, has the DCX mutation in only some of
his cells and it is thought that the subcortical band probably contains
mutated neurons and the overlying cortex has neurons without
the mutated allele [4]. Our patient, despite having the DCX
mutation in all of her cells, probably has a mosaic state due to X
inactivation in which neurons express either the normal or a
mutant DCX copy [3]. In both cases, the mutation resulted in
subcortical band heterotopia.
It is difﬁcult to explain how a subcortical band heterotopia
presented with such a different disease severity. One possible
explanation is the percentage of neurons that express the mutated
gene. Several authors suggested that in mosaics there may be a
critical percentage of mutated allele carrier cells. It has been
observed that patients with less that 30% mosaicism are clinically
unaffected, whereas those with more than 30% of the cells with the
mutated allele are symptomatic with SBH [3]. Another explana-
tion is the existence of other unknown factors inﬂuencing
epileptogenesis. This is corroborated by a recent study which
showed that seizure occurrence and response to antiepileptic
drugs were not determined by band thickness, suggesting that
epileptogenicity is not strictly related to the degree of agyria–
pachygyria [3].
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This family emphasises the large clinical heterogeneity that can
be found in SBH, and highlights the need for a careful evaluation of
transmission of this disease. To the best of your knowledge we
report the ﬁrst case in which the disease is transmitted by the
father.
Conﬂict of interest statement
None declared.References
[1] Leventer RJ. Genotype–phenotype correlation in lissencephaly and subcortical
band heterotopia: the key questions answered. J Child Neurol 2005;20(4):
307–12.
[2] Kato M, Dobyns WB. Lissencephaly and the molecular basis of neuronal
migration. Hum Mol Genet 2003;12(Spec No 1):R89–96.
[3] Bahi-Buisson N, Souville I, Fourniol FJ, Toussaint A, Moores CA, Houdusse A,
et al. New insights into genotype–phenotype correlations for the doublecortin-
related lissencephaly spectrum. Brain 2013;136(Pt 1):223–44.
[4] Kato M, Kanai M, Soma O, Takusa Y, Kimura T, Numakura C, et al. Mutation of
the doublecortin gene in male patients with double cortex syndrome: somatic
mosaicism detected by root analysis. Ann Neurol 2001;50(4):547–51
